Wed, April 7, 2021
Tue, April 6, 2021
Mon, April 5, 2021

Daina Graybosch Maintained (BOLT) at Buy with Increased Target to $37 on, Apr 6th, 2021

Daina Graybosch of SVB Leerink, Maintained "Bolt Biotherapeutics, Inc." (BOLT) at Buy with Increased Target from $36 to $37 on, Apr 6th, 2021.

Daina has made no other calls on BOLT in the last 4 months.



There are 3 other peers that have a rating on BOLT. Out of the 3 peers that are also analyzing BOLT, 0 agree with Daina's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Daina


  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $45 on, Tuesday, March 2nd, 2021
  • Michael Schmidt of "Guggenheim" Initiated at Strong Buy and Held Target at $42 on, Tuesday, March 2nd, 2021
  • Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $40 on, Tuesday, March 2nd, 2021